<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01421225</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-P00000231</org_study_id>
    <nct_id>NCT01421225</nct_id>
  </id_info>
  <brief_title>Closed-Loop Insulin Delivery in Children Less Than 7 Years of Age</brief_title>
  <official_title>Closed-Loop Insulin Delivery in Children Less Than 7 Years of Age</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Children’s Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Children’s Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are conducting this study to find out whether a new device can control
      blood sugar levels in children who have Type 1 diabetes. In Type 1 diabetes, children have
      high blood sugar levels because they do not make enough insulin. The standard treatment is to
      give insulin either by shots or using an insulin pump. A new device, called closed-loop
      insulin therapy, uses a continuous glucose monitor (CGMs) linked to an insulin pump by a
      computer. The CGM will send the sugar levels to a computer which automatically figures out
      how much insulin to give and then gives that amount of insulin through the insulin pump. It
      will give the child insulin to bring sugar levels down if they are high, and will give less
      insulin if the child's blood sugar is getting lower. Earlier research using closed-loop
      insulin therapy has shown the ability for it to improve diabetes care in adults and older
      children, but there has been no research of closed-loop insulin therapy in young children.
      This study will compare children's current insulin therapy with the closed-loop system. The
      knowledge that the investigators gain from this research will help us to figure out whether
      closed-loop therapy can work in young children, hopefully leading to better Type 1 diabetes
      care.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We will perform a randomized cross-over study of semi-closed-loop insulin therapy in children
      less than 7 years old with type 1 diabetes. Subjects will be admitted to the inpatient
      clinical research center for 48 hours. They will receive their standard home insulin therapy
      for one day and semi-closed-loop insulin therapy for the other day.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2011</start_date>
  <completion_date type="Actual">August 15, 2013</completion_date>
  <primary_completion_date type="Actual">August 15, 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Nocturnal Glycemic Control</measure>
    <time_frame>Participants will be followed for the duration of the 48 hour protocol.</time_frame>
    <description>Time spent within target glucose range based on the glucose meter measurements between 10 PM and 8 AM. The target range is 110-200 mg/dl as this is the American Diabetes Association defined target overnight range for this age group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-prandial Glycemic Control</measure>
    <time_frame>Participants will be followed for the duration of the 48 hour protocol</time_frame>
    <description>Peak post-prandial blood sugar between 8 AM and noon</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Interventions for Hypoglycemia</measure>
    <time_frame>Participants will be followed for the duration of the 48 hour protocol</time_frame>
    <description>The number of interventions for hypoglycemia between 10 PM - 8 AM.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pre-lunch Blood Glucose Level</measure>
    <time_frame>Participants will be followed for the duration of the 48 hour protocol</time_frame>
    <description>Blood glucose levels were documented at 12 pm just prior to being served lunch.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Type 1 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Standard Insulin Pump Therapy first, then Closed Loop</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard therapy day 1, Closed-Loop therapy day 2.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Closed Loop first, then Standard Insulin Pump Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Closed-loop therapy day 1, standard therapy day 2.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Closed-loop Insulin Pump therapy</intervention_name>
    <description>Subjects insulin doses were adjusted based on a proportional-integral-derivative algorithm using the continuous glucose monitor readings from 10 PM - noon.</description>
    <arm_group_label>Closed Loop first, then Standard Insulin Pump Therapy</arm_group_label>
    <arm_group_label>Standard Insulin Pump Therapy first, then Closed Loop</arm_group_label>
    <other_name>Continuous glucose monitor and computer-linked insulin pump</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard Insulin Pump Therapy</intervention_name>
    <description>Subjects insulin doses followed their usual home routine.</description>
    <arm_group_label>Closed Loop first, then Standard Insulin Pump Therapy</arm_group_label>
    <arm_group_label>Standard Insulin Pump Therapy first, then Closed Loop</arm_group_label>
    <other_name>Open-Loop Therapy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &lt; 7 years old

          -  Type 1 Diabetes (as diagnosed by outpatient endocrinologist) with duration greater
             than 6 months

          -  Treated with insulin pump therapy for greater than 6 weeks

        Exclusion Criteria:

          -  Any other chronic medical condition

          -  Weight below 10 kg as this is the minimal required weight for the amount of blood
             being drawn
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>7 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew Dauber, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston Children’s Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital Boston</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Dauber A, Corcia L, Safer J, Agus MS, Einis S, Steil GM. Closed-loop insulin therapy improves glycemic control in children aged &lt;7 years: a randomized controlled trial. Diabetes Care. 2013 Feb;36(2):222-7. doi: 10.2337/dc12-1079. Epub 2012 Oct 1.</citation>
    <PMID>23033237</PMID>
  </results_reference>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 19, 2011</study_first_submitted>
  <study_first_submitted_qc>August 19, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 22, 2011</study_first_posted>
  <results_first_submitted>August 29, 2017</results_first_submitted>
  <results_first_submitted_qc>August 3, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">August 7, 2018</results_first_posted>
  <last_update_submitted>August 7, 2018</last_update_submitted>
  <last_update_submitted_qc>August 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston Children’s Hospital</investigator_affiliation>
    <investigator_full_name>Garry Steil</investigator_full_name>
    <investigator_title>Assistant Professor of Pediatrics, Harvard Medical School</investigator_title>
  </responsible_party>
  <keyword>Closed Loop Insulin Delivery</keyword>
  <keyword>Diabetes</keyword>
  <keyword>Type 1 Diabetes</keyword>
  <keyword>Artificial pancreas</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Insulin, Globin Zinc</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Standard Insulin Pump Therapy First</title>
          <description>The subjects in this arm received Standard Insulin Pump therapy on day 1 followed by Closed-Loop Insulin therapy on day 2.
Closed-loop Insulin therapy: Subjects' insulin dose will be adjusted based on a proportional-integral-derivative algorithm using the continuous glucose monitor readings from 10 PM - noon.
Standard Insulin Pump Therapy: Patients will receive standard insulin pump therapy as per their usual home insulin protocol.</description>
        </group>
        <group group_id="P2">
          <title>Closed-Loop Insulin Therapy First</title>
          <description>The subjects in this arm receive closed-loop insulin therapy on day 1 followed by standard insulin pump therapy on day 2.
Closed-loop Insulin therapy: Subjects' insulin dose will be adjusted based on a proportional-integral-derivative algorithm using the continuous glucose monitor readings from 10 PM - noon.
Standard Insulin Pump Therapy: Patients will receive standard insulin pump therapy as per their usual home insulin protocol.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Standard Insulin Pump Therapy First</title>
          <description>The subjects in this arm received Standard Insulin Pump therapy on day 1 followed by Closed-Loop Insulin therapy on day 2.
Closed-loop Insulin therapy: Subjects' insulin dose will be adjusted based on a proportional-integral-derivative algorithm using the continuous glucose monitor readings from 10 PM - noon.
Standard Insulin Pump Therapy: Patients will receive standard insulin pump therapy as per their usual home insulin protocol.</description>
        </group>
        <group group_id="B2">
          <title>Closed-Loop Insulin Therapy First</title>
          <description>The subjects in this arm receive closed-loop insulin therapy on day 1 followed by standard insulin pump therapy on day 2.
Closed-loop Insulin therapy: Subjects' insulin dose will be adjusted based on a proportional-integral-derivative algorithm using the continuous glucose monitor readings from 10 PM - noon.
Standard Insulin Pump Therapy: Patients will receive standard insulin pump therapy as per their usual home insulin protocol.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="4"/>
            <count group_id="B2" value="6"/>
            <count group_id="B3" value="10"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>age</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.7" spread="1.3"/>
                    <measurement group_id="B2" value="5.5" spread="0.9"/>
                    <measurement group_id="B3" value="5.1" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Nocturnal Glycemic Control</title>
        <description>Time spent within target glucose range based on the glucose meter measurements between 10 PM and 8 AM. The target range is 110-200 mg/dl as this is the American Diabetes Association defined target overnight range for this age group.</description>
        <time_frame>Participants will be followed for the duration of the 48 hour protocol.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Insulin Pump Therapy</title>
            <description>Subjects will receive standard insulin pump therapy as per their usual home insulin protocol on day 1 or 2.</description>
          </group>
          <group group_id="O2">
            <title>Closed-Loop Insulin Therapy</title>
            <description>Subjects insulin doses will be adjusted based on a proportional-integral-derivative algorithm using the continuous glucose monitor readings from 10 PM - noon the following day on day 1 or 2.</description>
          </group>
        </group_list>
        <measure>
          <title>Nocturnal Glycemic Control</title>
          <description>Time spent within target glucose range based on the glucose meter measurements between 10 PM and 8 AM. The target range is 110-200 mg/dl as this is the American Diabetes Association defined target overnight range for this age group.</description>
          <units>Hours</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="0.77"/>
                    <measurement group_id="O2" value="5.3" spread="0.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We tested the number of nighttime (10 PM - 8 AM) hours glucose was in the target range (110-200 mg/dL) on each of the two nights for which the patient was followed (one night under Standard Insulin Pump Therapy; one night under Closed-loop Insulin Therapy)</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>The null hypothesis was that the number of hours would be the same (no effect of control).</non_inferiority_desc>
            <p_value>0.12</p_value>
            <p_value_desc>Statistical analysis was performed using a paired t-test.</p_value_desc>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>2.2</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post-prandial Glycemic Control</title>
        <description>Peak post-prandial blood sugar between 8 AM and noon</description>
        <time_frame>Participants will be followed for the duration of the 48 hour protocol</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Insulin Pump Therapy</title>
            <description>Subjects will receive standard insulin pump therapy as per their usual home insulin protocol on day 1 or 2.</description>
          </group>
          <group group_id="O2">
            <title>Closed-Loop Insulin Therpay</title>
            <description>Subjects insulin doses will be adjusted based on a proportional-integral-derivative algorithm using the continuous glucose monitor readings from 10 PM - noon the following day on day 1 or two.</description>
          </group>
        </group_list>
        <measure>
          <title>Post-prandial Glycemic Control</title>
          <description>Peak post-prandial blood sugar between 8 AM and noon</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="353" spread="24"/>
                    <measurement group_id="O2" value="367" spread="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Interventions for Hypoglycemia</title>
        <description>The number of interventions for hypoglycemia between 10 PM - 8 AM.</description>
        <time_frame>Participants will be followed for the duration of the 48 hour protocol</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Insulin Pump Therapy</title>
            <description>Subjects will receive standard insulin pump therapy as per their usual home insulin protocol on day 1 or 2.</description>
          </group>
          <group group_id="O2">
            <title>Closed-Loop Insulin Therapy</title>
            <description>Subjects insulin doses will be adjusted based on a proportional-integral-derivative algorithm using the continuous glucose monitor readings from 10 PM - noon the following day on day 1 or 2.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Interventions for Hypoglycemia</title>
          <description>The number of interventions for hypoglycemia between 10 PM - 8 AM.</description>
          <units>Interventions</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pre-lunch Blood Glucose Level</title>
        <description>Blood glucose levels were documented at 12 pm just prior to being served lunch.</description>
        <time_frame>Participants will be followed for the duration of the 48 hour protocol</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Insulin Pump Therapy</title>
            <description>Subjects will receive standard insulin pump therapy as per their usual home insulin protocol on day 1 or 2.</description>
          </group>
          <group group_id="O2">
            <title>Closed-Loop Insulin Therapy</title>
            <description>Subjects insulin doses will be adjusted based on a proportional-integral-derivative algorithm using the continuous glucose monitor readings from 10 PM - noon the following day on day 1 or 2.</description>
          </group>
        </group_list>
        <measure>
          <title>Pre-lunch Blood Glucose Level</title>
          <description>Blood glucose levels were documented at 12 pm just prior to being served lunch.</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="273" spread="24"/>
                    <measurement group_id="O2" value="189" spread="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Participants will be followed for the duration of the 48 hour protocol.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Standard Insulin Pump Therapy</title>
          <description>Subjects will receive standard insulin pump therapy as per their usual home insulin protocol on day 1 or 2.</description>
        </group>
        <group group_id="E2">
          <title>Closed-Loop Insulin Therapy</title>
          <description>Subjects insulin doses will be adjusted based on a proportional-integral-derivative algorithm using the continuous glucose monitor readings from 10 PM - noon the following day on day 1 or 2.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Medication Error</sub_title>
                <description>One episode where mealtime insulin was not administered due to a nursing error. The patient was transiently hyperglycemic until an additional dose of insulin was given. This was a minor event but was unexpected. No harm came to the patient.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Garry Steil (Assistant Prof. of Pediatrics)</name_or_title>
      <organization>Boston Children's Hospital</organization>
      <phone>617-355-7504</phone>
      <email>garry.steil@childrens.harvard.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

